Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 174.45 2.56
Cipla Lt 557.40 8.38
Ong Corp 444.60 2.17
Tata Stl 519.20 1.10
Ntpc Ltd 140.10 1.74
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-F D C Limited
F D C Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:531599NSE:FDCBloomberg:FDCLT@INReuters:FDC.BO
Market Lot: 1Face Value: 1ISIN Demat: INE258B01022
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Business
FDC, formerly FairDeal Corporation, is engaged in bulk drugs, formulations and food products. It has a presence in numerous therapeutic segments such as anti-infectives, dermatologicals, respiratory, haematinics and ophthalmics. Its plant in Roha manufactures pharma dosage forms, food products and bulk drugs for anti-rheumatic, anti-asthmatics, opthalmic and ENT segments. These bulk drugs are either exported (more than 80% of the production) or...   More..
Future Plans
One To One
Recent news
Latest News
FDC climbs on buyback news   -IRIS 22-Aug-12
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 2171.698308.537608.57
Other Income153.78381.64475.61
Total Income2325.478690.178084.18
Cost of goods sold1750.736306.345820.76
OPBDIT574.742383.832263.42
PAT343.011344.201583.32
Gross Block---
Equity capital177.83177.83180.83
EPS (Rs.)-7.548.68
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-10.48 - 19.038.64 - 12.21
Debt / Equity (x)---
Operating margin (% of OI)24.727.428.0
Net margin (% of OI)14.815.519.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
B-8, M I D C Industrial Estate
District Waluj
Aurangabad
Maharashtra-431 136
PHONE
(0240) 2554 407/ 2554 967
FAX
(0240) 2554 299
 
Board of Directors
Board Meetings
Date Purpose
06-SEP-14 To discuss the amalgamation of Soven Trading & Investment Company Private Limited, Sudipta Trading & Investment Company Private Limited, Transgene Trading & Investment Company Private Limited and Anand Synthochem Limited (collectively referred to as the "Transferor Companies") in FDC Limited ("Transferee Company" or "Company") and their respective shareholders. Further, in terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the equity shares of the Company will remain closed from August 28, 2014 to September 08, 2014 (both days inclusive). Accordingly, Directors /Designated employees shall not trade in the equity shares of the Company during the above said period.
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer